Ingersoll-Rand Aktie News

Ingersoll Rand Inc. (IR) Q4 2025 Earnings Call Transcript

DAVIDSON, N.C.--(BUSINESS WIRE)--Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life sciences and industrial solutions, reported strong results for both the fourth quarter and the full-year 2025. “Against the backdrop of a complex global environment, we delivered strong growth, earnings, and free cash flow, reflecting the resilience and execution strengt...

DAVIDSON, N.C., Feb. 11, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, declared today a regular quarterly cash dividend of $0.02 (two cents) per share of common stock payable on March 26, 2026, to stockholders of record on March 4, 2026.

DAVIDSON, N.C., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, announced that Vik Kini, chief financial officer, will participate in fireside chats at the following upcoming investor conferences:

Ingersoll Rand Inc. (IR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

DAVIDSON, N.C., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, will issue its fourth quarter 2025 earnings release after the market closes on Thursday, February 12, 2026.

DAVIDSON, N.C., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc., (NYSE: IR) a global provider of mission-critical flow creation and life science and industrial solutions, has acquired Scinomix, Inc., expanding the company's life sciences portfolio.

DAVIDSON, N.C., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, announced that Vicente Reynal, chairman and chief executive officer, Vik Kini, chief financial officer, and Scott Watson, senior vice president and general manager, Life Science Technologies, will present at the 2026 J.P...